NovaQuest appeared to be the VC, which was created in 1982. The main department of described VC is located in the Durham. The fund was located in North America if to be more exact in United States.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the NovaQuest, startups are often financed by Vivo Capital, Technology Partners, Essex Woodlands Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Roche Venture Fund, Radius Ventures, OrbiMed. In the next rounds fund is usually obtained by Aisling Capital, Roche Venture Fund, Radius Ventures.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Arvelle Therapeutics, Artisan Pharma, Sirion Therapeutics. The fund has no exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biopharma, Therapeutics.
Besides them, we counted 11 critical employees of this fund in our database.
The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2006. Despite it in 2019 the fund had an activity. Comparing to the other companies, this NovaQuest performs on 7 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations.
Related Funds
Funds with similar focus
Fund Name | Location |
Accelerating Commercialisation - AusIndustry | Australia, Australian Capital Territory, Canberra |
Eneva | Botafogo, Brazil, Rio de Janeiro |
Future Partners | Chiyoda, Japan |
Israeli Founders | Israel, Tel Aviv District, Tel Aviv-Yafo |
JNI | California, San Diego, United States |
Luma Ventures | Mazowieckie, Poland, Warsaw |
Tsinghua Technology Transfer Fund | Beijing, Beijing, China |
Yuexiu Group | China, Hong Kong, Hong Kong Island |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Arvelle Therapeutics | $196M | 18 Feb 2019 | Basel, Basel-City, Switzerland | ||
Artisan Pharma | $3M | 20 Jul 2010 | Massachusetts, United States | ||
Protemix | $14M | 04 Apr 2007 | Auckland, New Zealand | ||
Artisan Pharma | $39M | 06 Sep 2006 | Massachusetts, United States | ||
Sirion Therapeutics | 19 Jun 2006 | Tampa, Florida, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Arvelle Therapeutics | $196M | 18 Feb 2019 | Basel, Basel-City, Switzerland | ||
Artisan Pharma | $3M | 20 Jul 2010 | Massachusetts, United States | ||
Protemix | $14M | 04 Apr 2007 | Auckland, New Zealand | ||
Artisan Pharma | $39M | 06 Sep 2006 | Massachusetts, United States | ||
Sirion Therapeutics | 19 Jun 2006 | Tampa, Florida, United States |